142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

312566
Provision of epinephrine auto-injectors on K-12 public school buses

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014

Philip Welch, PhD, MCHES , Public & Allied Health, Bowling Green State University, Bowling Green, OH
Samantha Gardner, BA , Public & Allied Health, Bowling Green State University, Bowling Green, OH
Allison Pappenfuss, BA , Intercollegiate Athletics, Bowling Green State University, Bowling Green, OH
Background: Anaphylaxis is a serious medical condition. If left untreated, anaphylaxis can cause increased heart rate, low blood pressure, unconsciousness, or even death. The most common trigger of anaphylactic reactions are food proteins such as peanuts, eggs, and dairy. Food allergies affect between 4% and 8% of youths in developed countries. Other potential triggers include insect stings, medications, exercise, and (in rare cases) pollen. Provision of epinephrine via auto-injectors can mitigate anaphylactic reactions until emergency medical personnel arrive. Most school systems have established policies for stocking epinephrine auto-injectors in a centralized location for school personnel to use in the event of an anaphylactic reaction during normal school hours. What is less clear is the provision of epinephrine via auto-injectors on school buses where some students spend up to two hours or more each school day. Methods: 614 Directors of Transportation Services in K-12 public schools were contacted by telephone and interviewed about epinephrine auto-injector provision on public school buses. Directors were also asked about their perceptions of the problem, knowledge of how to use an auto-injector, and bus driver education about anaphylaxis. Results: Initial results suggest many school districts do not have policies for provision of epinephrine in the event of a serious allergic reaction by a student on a school bus. Furthermore, many districts lack appropriate training for drivers on how to recognize the warning signs of anaphylaxis and how to properly administer epinephrine using an auto-injector. Conclusions: Recommendations for policies aimed at protecting allergic youths on school buses will be discussed. The feasibility of stocking epinephrine auto-injectors on school buses will be examined.

Learning Areas:

Chronic disease management and prevention
Public health or related public policy

Learning Objectives:
Describe K-12 public school policies regarding provision of epinephrine auto-injectors on school buses Identify school policies that could be implemented to prevent and manage anaphylactic reactions on school buses

Keyword(s): School-Based Health, Chronic Disease Management and Care

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am Assistant Professor of Public Health at a large public institution. I have presented research at past APHA conferences. I teach graduate classes on statistics, research methods, and grant writing. I review manuscripts for Preventive Medicine, Prevetion of Chronic Diseases, and Journal of School Health.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4290.0: School Health Services